Insider Trading History of Humphrey Rachel

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Humphrey Rachel since 2016. This trader's CIK number is 1579781. At the time of last reporting, Humphrey Rachel was the Officer of Pyxis Oncology, Inc.. (stock ticker symbol PYXS). Also see all insider trading activities at Pyxis Oncology, Inc..

Note that in the past HUMPHREY RACHEL also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Cytomx Therapeutics, Inc. (CTMX) by Humphrey Rachel

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 CTMX 0 $0 40,000 $1,200,000 40,000 $264,599
2017 CTMX 0 $0 0 $0 15,117 $99,998
2016 CTMX 0 $0 0 $0 15,117 $99,998

Yearly summary of insider trading at Pyxis Oncology, Inc. (PYXS) by Humphrey Rachel

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 PYXS 0 $0 15,496 $15,924 0 $0


Insider trading activities at 2 companies by Humphrey Rachel:

1. Cytomx Therapeutics, Inc. (CTMX)

2. Pyxis Oncology, Inc. (PYXS)

Table 1. Insider trading of Cytomx Therapeutics, Inc. (CTMX) by Humphrey Rachel

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-03-02 CTMX Sale 16,160 30.00 484,800
2018-03-02 CTMX Option Ex 16,160 6.62 106,898
2018-02-28 CTMX Sale 23,840 30.00 715,200
2018-02-28 CTMX Option Ex 23,840 6.62 157,701
2017-12-15 CTMX Option Ex 15,117 6.62 99,998
2016-12-28 CTMX Option Ex 15,117 6.62 99,998

Table 2. Insider trading of Pyxis Oncology, Inc. (PYXS) by Humphrey Rachel

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-04-17 PYXS Sale 200 .97 194
2025-04-14 PYXS Sale 1,400 .97 1,362
2025-04-21 PYXS Sale 13,896 1.03 14,368

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Humphrey Rachel (Officer of Pyxis Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.